Joy Liu reports multiple share sales for VRTX (NASDAQ: VRTX) in Form 144 - Stock Titan
📅 Joy Liu filed a Form 144 to report proposed sales of Vertex Pharmaceuticals (VRTX) common stock.
💰 Four distinct sales were reported between December 29, 2025, and February 13, 2026.
📊 The largest transaction involved the sale of 9,320 shares on February 13, 2026.
💵 Gross proceeds for the reported sales ranged from approximately $255,576 to over $4.5 million.
🏦 Fidelity Brokerage Services LLC is listed as the broker handling these transactions.
🎁 A separate entry shows the vesting of 892 restricted shares granted on February 10, 2025.
⚖️ The filing confirms compliance with Rule 144 regarding resale restrictions for affiliates.
📝 The seller represents having no material adverse information undisclosed to the public.
Bullish Signals
- The filing demonstrates active liquidity and standard regulatory compliance by an insider, which is a neutral-to-positive signal of normal corporate governance.
- The inclusion of a recent equity grant (892 restricted shares vesting in February 2025) indicates ongoing compensation alignment between the executive/insider and the company.
Risk Factors
- The sale of 12,069 shares by an insider may be interpreted by some investors as a lack of confidence in near-term stock price appreciation.
- The timing of sales occurring in early 2026 suggests the insider is reducing their position or locking in gains at current market levels.
Full Analysis
Joy Liu, an affiliate of Vertex Pharmaceuticals Inc. (VRTX), has filed a Form 144 with the SEC to report proposed sales and recent transactions of company common stock. The filing details four specific sales occurring between late December 2025 and mid-February 2026, involving a total of 12,069 shares sold across multiple dates.
The reported transactions include the sale of 552 shares on December 29, 2025; 1,385 shares on January 5, 2026; 812 shares on February 12, 2026; and a larger block of 9,320 shares sold on February 13, 2026. These sales were executed through Fidelity Brokerage Services LLC and generated gross proceeds ranging from approximately $255,576 to over $4.5 million per transaction.
In addition to the sales, the filing discloses a grant or vesting event where Joy Liu received 892 restricted common shares on February 10, 2025, as compensation. The document serves as a standard regulatory notice under Rule 144 of the Securities Act of 1933, confirming that the seller does not possess any material non-public information regarding Vertex's operations.
The filing aggregates sales from the past three months and provides specific dates, share counts, and dollar amounts for each transaction. It also identifies the broker of record as Fidelity Brokerage Services LLC and notes the listing exchange as NASDAQ, ensuring compliance with resale restrictions for affiliates.
